A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects

Conditions:   Overweight Subjects;   Obese Subjects Interventions:   Drug: metformin;   Drug: digoxin;   Drug: IBI362;   Drug: warfarin;   Drug: atorvastatin Sponsor:   Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials